Geethanjali Dornadula

Author

Thomas Jefferson University

Also Known As

G Dornadula, GEETHANJALI DORNADULA, Geethanjali Dornadula

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University Jefferson College United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)University of Pennsylvania

About

Geethanjali Dornadula is an author at Thomas Jefferson University specializing in medicine, virology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	944
2	Engineering	2	2	71
3	Biochemistry	2	2	61
4	Biomolecular Engineering	2	2	260
5	Natural Sciences	1	1	45

Geethanjali Dornadula

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy Geethanjali Dornadula JAMA	1999	462
Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy Hui Zhang, Geethanjali Dornadula, Maria Beumont, New England Journal of Medicine	1998	425
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART Joseph Kulkosky, Derek M. Culnan, Jeanette Roman, Blood	2001	324
Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques Daria J. Hazuda, Steven D. Young, James P. Guare, Science Viral ReplicationSiv IntegraseImmunologyAntiviral DrugImmunotherapy	2004	283
Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells H Zhang, Geethanjali Dornadula, Roger J. Pomerantz Journal of Virology Viral ReplicationImmunologyMolecular BiologyReverse TranscriptionEndogenous Reverse Transcription	1996	146
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase P Levy-Mintz, Liping Duan, H Zhang, Journal of Virology Viral ReplicationImmunologyAntiviral DrugImmunotherapyIntracellular Expression	1996	114
Human Immunodeficiency Virus Type 1 Vif Protein Is an Integral Component of an mRNP Complex of Viral RNA and Could Be Involved in the Viral RNA Folding and Packaging Process Hui Zhang, Roger J. Pomerantz, Geethanjali Dornadula, Journal of Virology	2000	113
In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months Michele Di Mascio, Geethanjali Dornadula, Hui Zhang, Journal of Virology Latent Hiv-1 ReservoirPlasma DecaysViral PersistenceHuman RetrovirusImmunology	2003	61
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections Giuseppe Nunnari, Miguel Otero, Geethanjali Dornadula, AIDS	2002	57
HIV-1 Virions Produced from Replicating Peripheral Blood Lymphocytes Are More Infectious Than Those from Nonproliferating Macrophages Due to Higher Levels of Intravirion Reverse Transcripts: Implications for Pathogenesis and Transmission Geethanjali Dornadula, Hui Zhang, Shubhra Shetty, Virology Intravirion Reverse TranscriptsViral ReplicationViral PersistenceHigher LevelsHuman Retrovirus	1999	56

Page 1